A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity.
暂无分享，去创建一个
W. R. Bishop | J. Sloan | J. Sloan | R. Marks | P. Kirschmeier | C. Erlichman | S. Kaufmann | P. Svingen | A. Adjei | D. Cutler | J. Davis | L. Hanson | P. Atherton | D. Cutler | W. Bishop | Jenny N. Davis